Search - tctmd.com

Displaying 61 - 80 of 153

Sort: Relevancy | Date

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Conference News ESC 2017

P2Y12 Inhibitor Pretreatment Questioned in STEMI

Todd Neale

August 29, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

News Daily News

Prolonged Standing at Work Linked to Increased CV Risk

L.A. McKeown

August 21, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

CMS Reverses Its Course on Bundled Payments for MI, CABG

Caitlin E. Cox

August 16, 2017

News Daily News

Readmissions After Acute MI Not Only Confined to the Elderly

Yael L. Maxwell

August 09, 2017

News Daily News

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

Leah Lawrence

August 01, 2017

News Daily News

Real-World STEMI Study Shows Low Rate of Early Stent Thrombosis After Primary PCI

Todd Neale

July 28, 2017

News Daily News

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

L.A. McKeown

July 20, 2017

News Industry News

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

July 20, 2017

News Daily News

Implanted Devices May Help Determine Time and Cause of Death When Autopsy Falls Short

Yael L. Maxwell

June 26, 2017

News Daily News

Betrixaban Approved for Prevention of VTE

Michael O'Riordan

June 23, 2017

News Industry News

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

June 22, 2017

News Features

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

Caitlin E. Cox

June 14, 2017

News Daily News

Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds

Michael O'Riordan

June 14, 2017

News Daily News

Medical Journal Editors Back Off Ambitious Data-Sharing Mandate for Publication

Shelley Wood

June 07, 2017

News Daily News

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

L.A. McKeown

May 31, 2017

News Daily News

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

Michael O'Riordan

May 30, 2017

News Industry News

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

May 25, 2017

Advertisement

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

P2Y12 Inhibitor Pretreatment Questioned in STEMI

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Prolonged Standing at Work Linked to Increased CV Risk

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

CMS Reverses Its Course on Bundled Payments for MI, CABG

Readmissions After Acute MI Not Only Confined to the Elderly

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

Real-World STEMI Study Shows Low Rate of Early Stent Thrombosis After Primary PCI

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

Implanted Devices May Help Determine Time and Cause of Death When Autopsy Falls Short

Betrixaban Approved for Prevention of VTE

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds

Medical Journal Editors Back Off Ambitious Data-Sharing Mandate for Publication

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content